Reporting Manager
Trails Edge Capital Partners, LP
Symbol
LBRX
Shares outstanding
25,365,300 shares
Disclosed Ownership
1,268,265 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
31 Dec 2025, 17:00:17 UTC
Date of event
24 Dec 2025

Sponsored

Quoteable Key Fact

"Trails Edge Capital Partners, LP disclosed 5% ownership in LB Pharmaceuticals Inc Common Stock, par value $0.0001 (LBRX) on 24 Dec 2025."

Quick Takeaways

  • Trails Edge Capital Partners, LP filed SCHEDULE 13G for LB Pharmaceuticals Inc Common Stock, par value $0.0001 (LBRX).
  • Disclosed ownership: 5%.
  • Date of event: 24 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 31 Dec 2025, 17:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 5% 1,268,265 1,268,265 0 By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 5% 1,268,265 1,268,265 0 By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 5% 1,268,265 1,268,265 0 /s/ Ortav Yehudai Ortav Yehudai / Individual